Duchenne Muscular Dystrophy PBMC
Duchenne Muscular Dystrophy PBMC - Cryopreserved PBMCs in CryoStor CS10 from IRB-consented donors with clinically confirmed DMD, a monogenic dystrophin deficiency. Suitable for AAV capsid and transgene T cell response assays, immunophenotyping, transcriptomics, and genomic DNA for genotype work. Mutation-type and treatment stratification available.
Duchenne Muscular Dystrophy PBMC for Neuromuscular and Gene Therapy Research
Duchenne Muscular Dystrophy PBMC products are sourced from IRB-consented donors clinically diagnosed with Duchenne muscular dystrophy (DMD) and processed within 24 hours of collection under standardized SOPs. These cryopreserved peripheral blood mononuclear cells are stored in CryoStor® CS10 and shipped on dry ice. Research Use Only (RUO).
Disease Basis and Why PBMC
- DMD is an X-linked recessive monogenic disease caused by mutations in the DMD gene that abolish functional dystrophin, leaving the muscle sarcolemma mechanically fragile and prone to contraction-induced damage.
- Repeated muscle fiber injury provokes a chronic inflammatory response, with immune cell infiltration of dystrophic muscle contributing to degeneration, impaired regeneration, and fibro-adipose replacement.
- Corticosteroids remain a standard of care precisely because dampening this inflammatory component modifies disease course, which makes circulating immune cells a legitimate object of study.
- PBMCs are central to gene therapy development in DMD: T cell responses to AAV capsid and to transgene-derived dystrophin epitopes are a recognized safety and durability consideration, and are commonly assessed by ex vivo assays such as ELISpot and intracellular cytokine staining.
- Donor PBMCs also provide a genomic DNA source for mutation confirmation and a starting material for reprogramming and cell model generation.
- Unlike plasma or serum, PBMCs support live-cell immunophenotyping, antigen-specific stimulation, and single-cell transcriptomics from genotype-annotated donors.
Donor Stratification Available
- DMD mutation type where documented: deletion, duplication, nonsense, or exon-skip amenable
- Age band and ambulatory status (ambulatory versus non-ambulatory)
- Corticosteroid therapy status and duration
- Disease-modifying therapy: exon-skipping antisense oligonucleotide, gene therapy, or treatment-naive
- Documented cardiac and respiratory involvement
- Sex and self-reported race/ethnicity; Becker muscular dystrophy donors available on request
- Matched healthy controls available
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed DMD donors
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- Custom aliquots available; shipped on dry ice
- IRB-approved protocols and electronic informed consent, with parental or guardian permission for minors
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified DMD diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Genotype, ambulatory status, and treatment history where available
- Additional DMD-specific data available upon request
Applications
- T cell response assays against AAV capsid and transgene-derived epitopes
- Immunophenotyping of T cell, B cell, monocyte, and NK compartments
- Ex vivo stimulation and cytokine release profiling
- Bulk and single-cell transcriptomic analysis
- Monocyte and macrophage polarization studies relevant to muscle inflammation and fibrosis
- Genomic DNA extraction for mutation confirmation and genotype-phenotype work
- Starting material for iPSC reprogramming and disease modeling
- Immunomodulatory drug screening and mechanism-of-action studies
Other Duchenne Muscular Dystrophy Specimen Types
- Duchenne Muscular Dystrophy Plasma
- Duchenne Muscular Dystrophy Serum
- Duchenne Muscular Dystrophy Whole Blood
Compliance and Quality Assurance
- IRB-approved collections and protocols
- 21 CFR Part 11-compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Customization
Duchenne Muscular Dystrophy PBMC samples are shipped on dry ice and available in custom aliquots. For pricing, availability, international orders, or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs. To browse all donor cohorts and current stock, visit our human PBMCs page.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.